查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594001

医疗迴旋加速器市场：按产品类型、最终用户划分 - 全球预测 2025-2030

Medical Cyclotron Market by Product Type (AVF Cyclotron, Ring Cyclotron), End Users (Hospital, Pharmaceutical, Specialized Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医疗迴旋加速器市场价值为3.5195亿美元，预计到2024年将达到3.8735亿美元，复合年增长率为10.54%，到2030年将达到7.0993亿美元。

医用迴旋加速器 迴旋加速器是一种用于生产放射性核种的粒子加速器，对于各种医学诊断和治疗，特别是核医和 PET 扫描至关重要。对迴旋加速器的需求源于由于癌症和心血管疾病的增加而对先进医学诊断工具的需求增加。迴旋加速器对于及时有效地生产放射性同位素非常重要，放射性同位素的寿命很短，需要从生产现场快速供应到医疗场域。医疗迴旋加速器的最终用途包括医院、诊断中心和研究机构。

主要市场统计
基准年[2023] 35195万美元
预测年份 [2024] 3.8735 亿美元
预测年份 [2030] 70993万美元
复合年增长率（%） 10.54%

医疗迴旋加速器市场的成长受到技术进步、医疗保健支出增加以及核医疗法越来越多采用的影响。潜在的机会存在于新兴市场，这些市场对医疗保健基础设施的投资正在增加，迴旋加速器技术的进步提高了效率并降低了营运成本。此外，公共机构和私人公司之间的伙伴关係正在促进更广泛地获取同位素并改善分销网络。然而，他们面临挑战，包括安装迴旋加速器的初始成本高昂、放射性核种生产的复杂法规以及操作先进设备的熟练劳动力有限。

技术创新将为迴旋加速器小型化和自动化提供重要机会，使生产变得更加容易且更具成本效益，即使对于小型医疗设施也是如此。新同位素的研究扩大了诊断和治疗应用的范围并扩大了市场潜力。儘管市场竞争激烈，几乎没有大公司，但随着技术和医学的进步，市场有开拓空间，市场正在蓬勃发展。希望进入或拓展该市场的公司必须优先考虑高效且具成本效益的解决方案，并考虑创新和技能开拓伙伴关係，以有效应对监管环境。

市场动态：揭示快速发展的医疗迴旋加速器市场的关键市场洞察

供需的动态交互作用正在改变医疗迴旋加速器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 癌症和心血管疾病的增加
    • 使用 PET 扫描进行诊断治疗的需求
    • 政府积极致力于癌症的早期发现和诊断
  • 市场限制因素
    • 医用迴旋加速器高成本且缺乏适当的基础设施
  • 市场机会
    • 核子医学检测的普及和使用迴旋加速器的放射性药物生产的增加
    • 医用迴旋加速器的技术进步与产品开发
  • 市场问题
    • 使用迴旋加速器生产新放射性同位素的限制

波特五力：驾驭医疗迴旋加速器市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解医疗迴旋加速器市场的外部影响

外部宏观环境因素在塑造医疗迴旋加速器市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解医疗迴旋加速器市场的竞争格局

对医疗迴旋加速器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：医疗迴旋加速器市场供应商的绩效评估

FPNV定位矩阵是评估医疗迴旋加速器市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製医疗迴旋加速器市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，医疗迴旋加速器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症和心血管疾病的增加
      • 使用 PET 扫描进行诊断治疗的需求
      • 政府优先采取的癌症早期检测和诊断倡议
    • 抑制因素
      • 医用迴旋加速器成本高且缺乏适当的基础设施
    • 机会
      • 核子医学扫描的普及和使用迴旋加速器增加放射性药物的产量
      • 医用迴旋加速器的技术进步与产品开发
    • 任务
      • 使用迴旋加速器生产新放射性同位素的限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章医疗迴旋加速器市场：依产品类型

  • 介绍
  • AVF迴旋加速器
  • 环形迴旋加速器

第七章医疗迴旋加速器市场：依最终用户分类

  • 介绍
  • 医院
  • 製药
  • 专科诊所

第八章美洲医疗迴旋加速器市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太医疗迴旋加速器市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲医疗迴旋加速器市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Advanced Cyclotron Systems, Inc.
  • ALCEN
  • Best Cyclotron Systems
  • Dr. Fritz Faulhaber GmbH & Co. KG
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Ionetix Corporation
  • isoSolution Inc.
  • Molecular Cyclotrons Pvt Ltd.
  • Nueclear Healthcare Limited
  • Siemens AG
  • Sumitomo Heavy Industries, Ltd.
  • TeamBest
  • The Japan Steel Work Ltd.
  • Varian Medical Systems, Inc.
Product Code: MRR-957C47F92F8F

The Medical Cyclotron Market was valued at USD 351.95 million in 2023, expected to reach USD 387.35 million in 2024, and is projected to grow at a CAGR of 10.54%, to USD 709.93 million by 2030.

A medical cyclotron is a type of particle accelerator used in the production of radionuclides, which are crucial for various medical diagnostics and treatments, particularly in nuclear medicine and PET scans. The necessity of cyclotrons arises from the growing demand for advanced diagnostic tools in healthcare, driven by rising incidences of cancer and cardiovascular diseases. Cyclotrons are critical in enabling timely and efficient production of radioisotopes, which are short-lived and need quick delivery from production site to point of care. The end-use scope of medical cyclotrons spans hospitals, diagnostic centers, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 351.95 million
Estimated Year [2024] USD 387.35 million
Forecast Year [2030] USD 709.93 million
CAGR (%) 10.54%

Market growth for medical cyclotrons is influenced by technological advancements, rising healthcare spending, and increasing adoption of nuclear medicine therapies. Potential opportunities lie in emerging markets with increasing healthcare infrastructure investments, along with advancements in cyclotron technology enhancing efficiency and reducing operational costs. Additionally, partnerships between public institutions and private companies are encouraging wider access and improved distribution networks for isotopes. However, the market faces challenges such as the high initial cost of cyclotron installation, regulatory complexity surrounding radionuclide production, and a limited skilled workforce to operate sophisticated equipment.

Innovation presents significant opportunities in miniaturization and automation of cyclotrons, which would make production more accessible and cost-effective for smaller healthcare facilities. Research into new isotopes can expand the range of diagnostic and therapeutic applications, thus broadening market potential. The nature of the market is competitive, with few major players dominating, yet it remains dynamic with continued scope for development in response to technological and medical advancements. Companies looking to enter or expand in this market should prioritize high-efficiency, cost-effective solutions and consider partnerships for technological innovation and skill development to navigate the regulatory landscape effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Cyclotron Market

The Medical Cyclotron Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cancer and cardiovascular diseases
    • Demand for diagnostics treatments with PET scans
    • Favorable government initiatives for the early detection and diagnosis of cancer
  • Market Restraints
    • High cost of medical cyclotron and lack of proper infrastructure
  • Market Opportunities
    • Proliferation of nuclear medicine scans and increasing radiopharmaceutical production with cyclotron
    • Technological advancements and product developments in medical cyclotron
  • Market Challenges
    • Limitations related to the use of cyclotrons for the production of novel radioisotopes

Porter's Five Forces: A Strategic Tool for Navigating the Medical Cyclotron Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Cyclotron Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Cyclotron Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Cyclotron Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Cyclotron Market

A detailed market share analysis in the Medical Cyclotron Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Cyclotron Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Cyclotron Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Cyclotron Market

A strategic analysis of the Medical Cyclotron Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Cyclotron Market, highlighting leading vendors and their innovative profiles. These include Advanced Cyclotron Systems, Inc., ALCEN, Best Cyclotron Systems, Dr. Fritz Faulhaber GmbH & Co. KG, GE Healthcare, IBA Radiopharma Solutions, Ionetix Corporation, isoSolution Inc., Molecular Cyclotrons Pvt Ltd., Nueclear Healthcare Limited, Siemens AG, Sumitomo Heavy Industries, Ltd., TeamBest, The Japan Steel Work Ltd., and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Cyclotron Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across AVF Cyclotron and Ring Cyclotron.
  • Based on End Users, market is studied across Hospital, Pharmaceutical, and Specialized Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cancer and cardiovascular diseases
      • 5.1.1.2. Demand for diagnostics treatments with PET scans
      • 5.1.1.3. Favorable government initiatives for the early detection and diagnosis of cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of medical cyclotron and lack of proper infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of nuclear medicine scans and increasing radiopharmaceutical production with cyclotron
      • 5.1.3.2. Technological advancements and product developments in medical cyclotron
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations related to the use of cyclotrons for the production of novel radioisotopes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Cyclotron Market, by Product Type

  • 6.1. Introduction
  • 6.2. AVF Cyclotron
  • 6.3. Ring Cyclotron

7. Medical Cyclotron Market, by End Users

  • 7.1. Introduction
  • 7.2. Hospital
  • 7.3. Pharmaceutical
  • 7.4. Specialized Clinics

8. Americas Medical Cyclotron Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Medical Cyclotron Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Medical Cyclotron Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Cyclotron Systems, Inc.
  • 2. ALCEN
  • 3. Best Cyclotron Systems
  • 4. Dr. Fritz Faulhaber GmbH & Co. KG
  • 5. GE Healthcare
  • 6. IBA Radiopharma Solutions
  • 7. Ionetix Corporation
  • 8. isoSolution Inc.
  • 9. Molecular Cyclotrons Pvt Ltd.
  • 10. Nueclear Healthcare Limited
  • 11. Siemens AG
  • 12. Sumitomo Heavy Industries, Ltd.
  • 13. TeamBest
  • 14. The Japan Steel Work Ltd.
  • 15. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. MEDICAL CYCLOTRON MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL CYCLOTRON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MEDICAL CYCLOTRON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MEDICAL CYCLOTRON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL CYCLOTRON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MEDICAL CYCLOTRON MARKET DYNAMICS
  • TABLE 7. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY AVF CYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY RING CYCLOTRON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL CYCLOTRON MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MEDICAL CYCLOTRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM MEDICAL CYCLOTRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM MEDICAL CYCLOTRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. MEDICAL CYCLOTRON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. MEDICAL CYCLOTRON MARKET, FPNV POSITIONING MATRIX, 2023